{"id":"W2485574993","doi":"10.1182/blood.v122.21.577.577","title":"The First In Vitro and In Vivo Assessment Of Anfibatide, a Novel Glycoprotein Ib Antagonist, In Mice and In a Phase I Human Clinical Trial","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Von Willebrand factor; Platelet; In vivo; Hemostasis; Thrombus; Ex vivo; Fibrinogen; Pharmacology; Antithrombotic; Tirofiban; Medicine; Platelet adhesiveness; Chemistry; Platelet aggregation inhibitor; Platelet membrane glycoprotein; In vitro; Immunology; Internal medicine; Biology; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001906188,0.001314257,0.001492201,0.0003524362,0.0003546184,0.001211917,0.0005223746,0.00147566,0.003491703],"category_scores_gemma":[0.0006426068,0.0003625745,0.001018305,0.0002745795,0.0005532981,0.0007686748,0.0001684607,0.002755226,0.0008792417],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004805422,"about_ca_system_score_gemma":0.0007096363,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003555948,"about_ca_topic_score_gemma":0.0007239842,"domain_scores_codex":[0.9994274,0.0002067915,0.00005098445,0.000100643,0.00007772287,0.0001364577],"domain_scores_gemma":[0.9994633,0.0000712081,0.0001254928,0.00006980518,0.00006455863,0.000205659],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1197298,0.03887482,0.00198781,0.002186108,0.001390525,0.0006665504,0.0002850389,0.002503447,0.6916044,0.001137568,0.01755919,0.1220746],"study_design_scores_gemma":[0.08438329,0.725045,0.00633211,0.0002021933,0.001600384,0.001533957,0.0001175688,0.002323764,0.1364692,0.0008215709,0.04108375,0.00008726606],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9273239,0.02395219,0.01618419,0.00237271,0.001650351,0.007856533,0.007848702,0.0008187983,0.01199277],"genre_scores_gemma":[0.9437897,0.01298292,0.009467851,0.003024463,0.0006390394,0.006841615,0.008344226,0.0001812097,0.01472902],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003491703,"threshold_uncertainty_score":0.0116809,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03136198330342582,"score_gpt":0.3585422534753887,"score_spread":0.3271802701719628,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}